The Foundry® Investors

The Foundry is funded by Split Rock Partners and Morgenthaler Ventures. One important reason why The Foundry is such a valuable partner is its strong financial backing and close relationships with experienced entrepreneurs and investors in the medical device community. As such, The Foundry has helped raise over $200 million for our portfolio companies in various stages of financings from such notable venture capital firms as:

ABS Ventures
Advanced Technology Ventures
Bluebird Development, LLC
Cutlass Capital
Delphi Ventures
Frazier Healthcare Ventures
H & Q Capital Management
Latterell Venture Partners
Morgan Stanley
Morgenthaler
New Enterprise Associates
New Venture Partners
Neuroventures
OrbiMed Advisors
Oxford Bioscience Partners
Proquest
Schroder Ventures Life Sciences
Split Rock Partners, co-manager of St. Paul Venture Capital
Three Arch Partners
Venrock Associates

 

 

 

 

 

| The Process | The Team | The Portfolio | More Info |

 

 
the Foundry